NR AMEG
AU Walker,L.C.; LeVine,H.3rd
TI Proteopathy: the next therapeutic frontier?
QU Current Opinion in Investigational Drugs (London, England : 2000) 2002 May; 3(5): 782-7
PT journal article
AB The abnormal conformation and assembly of proteins is a probable cause of many degenerative diseases of old age. These proteopathies include such clinically disparate neurological disorders as Alzheimer's disease. Parkinson's disease and Creutzfeldt-Jakob disease, as well as a variety of non-neurological maladies. The involvement of protein pathology in these diseases is well established and we are beginning to understand the process whereby proteins self-assemble and injure tissues; however, we remain largely in the dark regarding the fundamental origins of the proteopathies. Our present knowledge suggests three broad therapeutic approaches to abrogating the proteopathic cascade: reduce the production of the offending proteins, prevent their self-assembly, or promote their removal.
AD CNS Pharmacology, Pfizer Ann Arbor Laboratories, MI 48105, USA. lary.walker@pfizer.com
SP englisch
PO England